Literature DB >> 17613352

Viral hepatitis and hepatocellular carcinoma.

Carlos Romero Marrero1, Jorge A Marrero.   

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common tumor worldwide, and one of the fastest rising tumors as a result of chronic hepatitis B and C infection. The patients at risk for developing HCC are those with underlying cirrhosis secondary to viral hepatitis. External factors such as alcohol, tobacco, obesity, and diabetes increase the risk of HCC among those with chronic viral hepatitis. Surveillance of patients with cirrhosis with alpha-fetoprotein and ultrasound has been shown to reduce survival. The diagnosis of HCC is established by the presence of an arterially enhancing mass in the presence of cirrhosis. Viral hepatitis represents an opportunity for prevention of HCC.

Entities:  

Mesh:

Year:  2007        PMID: 17613352     DOI: 10.1016/j.arcmed.2006.09.004

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  11 in total

1.  Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma.

Authors:  Manal M Hassan; Reham Abdel-Wahab; Ahmed Kaseb; Ahmed Shalaby; Alexandria T Phan; Hashem B El-Serag; Ernest Hawk; Jeff Morris; Kanwal Pratap Singh Raghav; Ju-Seog Lee; Jean-Nicolas Vauthey; Gehan Bortus; Harrys A Torres; Christopher I Amos; Robert A Wolff; Donghui Li
Journal:  Gastroenterology       Date:  2015-03-30       Impact factor: 22.682

2.  Decreased expression of p39 is associated with a poor prognosis in human hepatocellular carcinoma.

Authors:  Jeng-Wei Lu; Jan-Gowth Chang; Kun-Tu Yeh; Rong-Ming Chen; Jeffrey J P Tsai; Rouh-Mei Hu
Journal:  Med Oncol       Date:  2010-10-09       Impact factor: 3.064

3.  Liver stem/progenitor cells in the canals of Hering: cellular origin of hepatocellular carcinoma with bile duct tumor thrombi?

Authors:  Ningfu Peng; Lequn Li; Xiang Cai; Shaozao Tan; Ting Wu
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

4.  Expression of protein kinase C family in human hepatocellular carcinoma.

Authors:  Hsiu-Chin Lu; Fen-Pi Chou; Kun-Tu Yeh; Ya-Sian Chang; Nicholas C Hsu; Jan-Gowth Chang
Journal:  Pathol Oncol Res       Date:  2009-12-01       Impact factor: 3.201

5.  Naturally occurring hepatitis C virus subgenomic deletion mutants replicate efficiently in Huh-7 cells and are trans-packaged in vitro to generate infectious defective particles.

Authors:  Laura Pacini; Rita Graziani; Linda Bartholomew; Raffaele De Francesco; Giacomo Paonessa
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

6.  No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations.

Authors:  Hiromi Sawai; Nao Nishida; Hamdi Mbarek; Koichi Matsuda; Yoriko Mawatari; Megumi Yamaoka; Shuhei Hige; Jong-Hon Kang; Koichi Abe; Satoshi Mochida; Masaaki Watanabe; Masayuki Kurosaki; Yasuhiro Asahina; Namiki Izumi; Masao Honda; Shuichi Kaneko; Eiji Tanaka; Kentaro Matsuura; Yoshito Itoh; Eiji Mita; Masaaki Korenaga; Keisuke Hino; Yoshikazu Murawaki; Yoichi Hiasa; Tatsuya Ide; Kiyoaki Ito; Masaya Sugiyama; Sang Hoon Ahn; Kwang-Hyub Han; Jun Yong Park; Man-Fung Yuen; Yusuke Nakamura; Yasuhito Tanaka; Masashi Mizokami; Katsushi Tokunaga
Journal:  BMC Med Genet       Date:  2012-06-19       Impact factor: 2.103

7.  Overexpression of endothelin 1 triggers hepatocarcinogenesis in zebrafish and promotes cell proliferation and migration through the AKT pathway.

Authors:  Jeng-Wei Lu; Chung-Yi Liao; Wan-Yu Yang; Yueh-Min Lin; Shiow-Lian Catherine Jin; Horng-Dar Wang; Chiou-Hwa Yuh
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

8.  Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.

Authors:  Hiromi Sawai; Nao Nishida; Seik-Soon Khor; Masao Honda; Masaya Sugiyama; Natsumi Baba; Kayoko Yamada; Norie Sawada; Shoichiro Tsugane; Kazuhiko Koike; Yuji Kondo; Hiroshi Yatsuhashi; Shinya Nagaoka; Akinobu Taketomi; Moto Fukai; Masayuki Kurosaki; Namiki Izumi; Jong-Hon Kang; Kazumoto Murata; Keisuke Hino; Sohji Nishina; Akihiro Matsumoto; Eiji Tanaka; Naoya Sakamoto; Koji Ogawa; Kazuhide Yamamoto; Akihiro Tamori; Osamu Yokosuka; Tatsuo Kanda; Isao Sakaida; Yoshito Itoh; Yuichiro Eguchi; Satoshi Oeda; Satoshi Mochida; Man-Fung Yuen; Wai-Kay Seto; Yong Poovorawan; Nawarat Posuwan; Masashi Mizokami; Katsushi Tokunaga
Journal:  Sci Rep       Date:  2018-05-21       Impact factor: 4.379

9.  Liver-specific expressions of HBx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafish.

Authors:  Jeng-Wei Lu; Wan-Yu Yang; Su-Mei Tsai; Yueh-Min Lin; Pen-Heng Chang; Jim-Ray Chen; Horng-Dar Wang; Jen-Leih Wu; Shiow-Lian Catherine Jin; Chiou-Hwa Yuh
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

10.  Does Pay-For-Performance Program Increase Providers Adherence to Guidelines for Managing Hepatitis B and Hepatitis C Virus Infection in Taiwan?

Authors:  Huei-Ju Chen; Nicole Huang; Long-Sheng Chen; Yiing-Jenq Chou; Chung-Pin Li; Chen-Yi Wu; Yu-Chia Chang
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.